Improvement of the Outcome of the Saphenous Vein Graft when Connected to the Internal Thoracic Artery

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2024 Nov 4

PMID 39494236

Authors

Konstantinos Katsavrias

Sotirios Prapas

Antonio M Calafiore

David Taggart

Dimitrios Angouras

Dimitrios Iliopoulos

Michele Di Mauro

Styliani Papandreopoulos

Panayiotis Zografos

Dimitrios Dougenis

Affiliations

Soon will be listed here.

Abstract

Background: Since 2000, we have been grafting the right coronary artery system (RCAs) using the proximal portion of the right internal thoracic artery (RITA) as the inflow of the saphenous vein graft (SVG) to increase the number of patients undergoing beating heart complete myocardial revascularization.

Methods: From 2000 to 2022, 928 consecutive patients underwent SVG on the RCAs. In 546 patients (58.8%), the inflow was the RITA (I-graft group), and in 382 patients (41.2%), the inflow was the aorta (Ao-graft group). The inclusion criteria were age ≤75 years, ejection fraction >35%, only one SVG per patient, bilateral internal thoracic arteries as a Y-graft on the left system (three-vessel disease, = 817, 88.0%) or left internal thoracic artery on the left anterior descending artery and RITA + SVG on the RCAs (two-vessel disease, = 111, 12.0%). Propensity matching identified 306 patients per group. After a median follow-up of 8 (5-10) years, graft patency was assessed by coronary computed tomographic angiography in 132 patients (64 in the I-graft group and 68 in the Ao-graft group).

Results: Early results were similar in both groups. The I-graft group had higher 10-year survival and freedom from main adverse cardiac events (90.0 ± 2.0 vs. 80.6 ± 3.8, = 0.0162, and 81.3 ± 2.7 vs. 64.7 ± 5.6, = 0.0206, respectively). When RITA was the inflow, SVG had a higher estimated 10-year patency rate (82.8% ± 6.5 vs. 58.8% ± 7.4, = 0.0026) and a smaller inner lumen diameter (2.7 ± 0.4 vs. 3.4 ± 0.6 mm, < 0.0001).

Conclusion: When the inflow is the RITA, SVG grafted to the RCAs (I-graft) may result in a higher patency rate and better outcome than when the inflow is the ascending aorta (Ao-graft). The continuous supply of nitric oxide by RITA may be the cause of the higher patency rate of the I-graft, which can behave like an arterial conduit.

References

Samano N, Geijer H, Liden M, Fremes S, Bodin L, Souza D . The no-touch saphenous vein for coronary artery bypass grafting maintains a patency, after 16 years, comparable to the left internal thoracic artery: A randomized trial. J Thorac Cardiovasc Surg. 2015; 150(4):880-8. DOI: 10.1016/j.jtcvs.2015.07.027. View

Tinica G, Chistol R, Iliescu D, Furnica C . Long-term graft patency after coronary artery bypass grafting: Effects of surgical technique. Exp Ther Med. 2019; 17(1):359-367. PMC: 6307371. DOI: 10.3892/etm.2018.6929. View

Prapas S, Calafiore A, Katsavrias K, Panagiotopoulos I, Linardakis I, Tancredi F . Anaortic coronary surgery using the Π-circuit is associated with a low incidence of perioperative neurological complications. Eur J Cardiothorac Surg. 2018; 54(5):884-888. DOI: 10.1093/ejcts/ezy224. View

Uematsu M, Ohara Y, Navas J, Nishida K, Murphy T, Alexander R . Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am J Physiol. 1995; 269(6 Pt 1):C1371-8. DOI: 10.1152/ajpcell.1995.269.6.C1371. View

Pesce M, Pompilio G, Bartunek J . The LIMA: A Drug-Eluting Graft and Coronary Flow Shock Absorber. Mayo Clin Proc. 2023; 98(1):15-17. DOI: 10.1016/j.mayocp.2022.11.010. View

Hwang H, Koo B, Oh S, Kim K . Morphologic changes of the saphenous vein Y-composite graft based on the left internal thoracic artery: 1-year intravascular ultrasound study. J Thorac Cardiovasc Surg. 2014; 149(2):487-93. DOI: 10.1016/j.jtcvs.2014.08.056. View

Porter K, Nydahl S, Dunlop P, Varty K, Thrush A, London N . The development of an in vitro flow model of human saphenous vein graft intimal hyperplasia. Cardiovasc Res. 1996; 31(4):607-14. View

Broeders M, Doevendans P, Maessen J, van Gorsel E, Egbrink M, Daemen M . The human internal thoracic artery releases more nitric oxide in response to vascular endothelial growth factor than the human saphenous vein. J Thorac Cardiovasc Surg. 2001; 122(2):305-9. DOI: 10.1067/mtc.2001.113602. View

Chiu J, Chien S . Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev. 2011; 91(1):327-87. PMC: 3844671. DOI: 10.1152/physrev.00047.2009. View

10.

Chester A, Buttery L, Borland J, Springall D, Rothery S, Severs N . Structural, biochemical and functional effects of distending pressure in the human saphenous vein: implications for bypass grafting. Coron Artery Dis. 1998; 9(2-3):143-51. View

11.

Gaudino M, Alexander J, Bakaeen F, Ballman K, Barili F, Calafiore A . Randomized comparison of the clinical outcome of single versus multiple arterial grafts: the ROMA trial-rationale and study protocol. Eur J Cardiothorac Surg. 2017; 52(6):1031-1040. DOI: 10.1093/ejcts/ezx358. View

12.

Hwang H, Koo B, Yeom S, Kim T, Kim K . Endothelial Shear Stress of the Saphenous Vein Composite Graft Based on the Internal Thoracic Artery. Ann Thorac Surg. 2017; 105(2):564-571. DOI: 10.1016/j.athoracsur.2017.08.025. View

13.

Ranjan V, Xiao Z, Diamond S . Constitutive NOS expression in cultured endothelial cells is elevated by fluid shear stress. Am J Physiol. 1995; 269(2 Pt 2):H550-5. DOI: 10.1152/ajpheart.1995.269.2.H550. View

14.

Isobe N, Kaneko T, Taniguchi K, Oshima S . Comparison of the rheologic parameters in left internal thoracic artery grafts with those in saphenous vein grafts. Circ J. 2005; 69(6):700-6. DOI: 10.1253/circj.69.700. View

15.

Filho J, Pimentel M, Filho H . Composite graft and remodeling of the saphenous vein in coronary artery bypass graft. JTCVS Open. 2022; 11:129-130. PMC: 9510823. DOI: 10.1016/j.xjon.2022.01.028. View

16.

Levesque M, Nerem R, Sprague E . Vascular endothelial cell proliferation in culture and the influence of flow. Biomaterials. 1990; 11(9):702-7. DOI: 10.1016/0142-9612(90)90031-k. View

17.

Meirson T, Orion E, Di Mario C, Webb C, Patel N, Channon K . Flow patterns in externally stented saphenous vein grafts and development of intimal hyperplasia. J Thorac Cardiovasc Surg. 2015; 150(4):871-8. DOI: 10.1016/j.jtcvs.2015.04.061. View

18.

Prapas S, Katsavrias K, Gaudino M, Puskas J, Di Mauro M, Zografos P . Saphenous vein to the right coronary system from the right thoracic artery or the aorta. Long-term propensity-matched results of 2 groups. Eur J Cardiothorac Surg. 2024; 65(3). DOI: 10.1093/ejcts/ezae060. View

19.

Benussi B, Gatti G, Gripshi F, Biondi F, Porcari A, Ruggiero D . Clinical Validation of a Coronary Surgery Technique That Minimizes Aortic Manipulation. Ann Thorac Surg. 2018; 107(4):1166-1173. DOI: 10.1016/j.athoracsur.2018.09.063. View

20.

Taggart D, Webb C, DeSouza A, Yadav R, Channon K, De Robertis F . Long-term performance of an external stent for saphenous vein grafts: the VEST IV trial. J Cardiothorac Surg. 2018; 13(1):117. PMC: 6245530. DOI: 10.1186/s13019-018-0803-9. View